HND-009: C4 & C6-enriched triglycerides increase postprandial circulating levels: a randomized trial

Introduction: Short chain fatty acids (SCFA) are increasingly recognized for their potential ability to alleviate obesity-associated chronic low-grade inflammation and disturbed substrate and energy homeostasis. Evidence suggests that an increase in circulating SCFA might be necessary to induce beneficial alterations in energy metabolism. Here, we aimed to study whether a single orally administrated SCFA incorporated into triglycerides reach the circulation and affect postprandial metabolism in men with overweight/obesity.

Methods: A double-blind, placebo-controlled, randomized, crossover study was conducted at Maastricht University with fourteen men with overweight/obesity (BMI 25-35 kg/m2) of which twelve men finished all testdays and were included for analysis. The participants received a liquid high milkfat mixed meal test containing either a low (650 mg), medium (1,325 mg), or high dose (2,000 mg) of Akovita SCT or a placebo (sunflower oil) in randomized order. Blood was sampled at baseline and after ingestion for 6 h for the primary outcome plasma butyrate and hexanoate concentration. Secondary outcomes included hydrogen breath, appetite, gastrointestinal complaints, circulating glucagon-like peptide 1, free fatty acids, glucose, triglycerides, insulin, and cytokines concentrations.

Results: All doses were well-tolerated. The medium dose increased (P < 0.05) and the high dose tended to increase (P < 0.10) postprandial circulating butyrate and both doses increased circulating hexanoate (P < 0.05) compared to placebo whereas the low dose did not. Nevertheless, a single dose of Akovita SCT supplementation did not affect any secondary outcomes compared to placebo.

Conclusion: Akovita SCT increased postprandial circulating butyrate and hexanoate. Future randomized clinical trials should investigate whether long-term Akovita SCT supplementation can aid in the treatment or prevention of metabolic disorders.

1. Conflict of interest: KL, LS and AH are employees of AAK Netherlands BV.
2. Funding: AAK Netherlands BV, Zaandijk, The Netherlands

Euro Fed Lipid e.V.
Data collection on our website

The Internet pages partly use so-called cookies. Cookies do not damage your computer and do not contain viruses. Cookies serve to make our offer more user-friendly, effective and safer. Cookies are small text files that are stored on your computer and saved by your browser.

Most of the cookies we use are so-called "session cookies". They are automatically deleted at the end of your visit. Other cookies remain stored on your computer until you delete them. These cookies enable us to recognize your browser the next time you visit us.

You can set your browser in such a way that you are informed about the setting of cookies and allow cookies only in individual cases, exclude the acceptance of cookies for certain cases or in general and activate the automatic deletion of cookies when closing the browser. If cookies are deactivated, the functionality of this website may be limited.

Cookies that are required to carry out the electronic communication process or to provide certain functions you have requested (e.g. shopping basket function) are stored on the basis of Art. 6 Para. 1 lit. f DSGVO. The website operator has a legitimate interest in the storage of cookies for the technically error-free and optimized provision of his services. Insofar as other cookies (e.g. cookies to analyze your surfing behavior) are stored, these are treated separately in this data protection declaration.